Marion Dorsch, Chief Scientific Officer at Blueprint Medicines Corp (BPMC), sold 4,600 shares at $100.07 ($460K) on 2018-03-15, disclosed to the SEC on 2018-03-19.
Open-market sale of $460k BPMC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $100.07 | 2,300 | $230K | 50.0% |
| 2 | $100.07 | 2,300 | $230K | 50.0% |
| Total | $100.07 avg | 4,600 | $460K | 100% |
| Filing → |
| BPMC | SELL | 2020-10-08 | $455K | — | Filing → |
| BPMC | SELL | 2020-09-25 | $409K | — | Filing → |
| BPMC | SELL | 2020-06-23 | $363K | — | Filing → |